Device Trial Radar · NCT01171625
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Last checked: Nov 20, 2026Latest source record: Apr 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
283
Actual
Start
Oct 2007
Primary completion
Sep 2018
Study completion Sep 2018
Sponsor
- Lead sponsor
- Edwards LifesciencesPublic (EW)
- Sponsor type
- Industry
- First posted
- Jul 28, 2010
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to demonstrate the long term safety and effectiveness of the Carpentier-Edwards PERIMOUNT Magna Ease Valves in patients undergoing aortic valve replacement with or without concomitant procedures requiring cardiopulmonary bypass.
Conditions
- Coronary Artery Disease
- Aortic Valve Disorder
- Heart Failure
- Aortic Valve Stenosis
- Aortic Valve Insufficiency
Interventions
Implantation of CEP Magna Ease Model 3300TFXDevice
Heart Valve Surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Subject's Percentage of Long Term Safety PerformanceTime frame: 31 days through 8 years post-implant
- Number of Subject's in NYHA Functional Class I or II at 8 Year Post-ImplantTime frame: 8 years post-implant
- Subject's New York Heart Association (NYHA) Functional Class at 8 Years Post-Implant Compared to BaselineTime frame: 8 Years post-implant
Locations
13 sites in 6 countries. Site status is shown where the registry gives one.
Mercy General Hospital
Sacramento, California
Cooper University Hospital
Camden, New Jersey
Morristown Memorial Hospital
Morristown, New Jersey
10 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.